2015 Complication IT Provider 
The Medical Futurist
JUNE 21, 2025
In 2015, surgeons in Manchester, UK have performed the first bionic eye implant for an AMD patient using Second Sight’s innovation. Researchers say that the implant cannot provide any highly detailed vision – but it can help patients detect distinct patterns such as door frames and shapes. How far can you see and hear?
Physician's Weekly
JUNE 19, 2025
Gowin and his colleagues analyzed data from 1,003 adults between 22 and 36 years of age who had functional magnetic resonance imaging (fMRI), urine toxicology, and cannabis use results collected at one academic site between 2012 and 2015 as part of the Human Connectome Project. It’s more complicated than that. The cohort (mean age, 28.7
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Doctor On Demand
APRIL 16, 2025
This may mean you’re not getting enough oxygen, which can cause serious complications. For more severe symptoms, in-person care may be the recommended course of treatment, and your virtual provider can help you make that decision. Am I at risk for complications due to my medical history? What warning signs should I watch for?
FDA Law
JUNE 30, 2022
As the drug distribution industry is well aware, and as blogged about here , on February 4, 2022, FDA published its long-awaited proposed rule titled “ National Standards for the Licensure of Wholesale Drug Distributors and Third-party Logistic Providers ” (87 Fed. 2) State regulation of third-party logistics providers. 6,708 (Feb.
33 Charts
OCTOBER 2, 2021
Inconsistency in care delivery So as every provider shapes her practice around MyChart, each will do it in a slightly different way. But this may not be consistently applied by other providers in the same group. Crucial that we fix this. And individual practice styles are fine. The problem comes with call and cross-coverage.
FDA Law
AUGUST 11, 2024
The approved labeling for AUVI-Q includes warnings and precautions regarding emergency treatment, injection-related complications, serious infections at the injection site, allergic reactions associated with sulfite, and disease interactions. August 2024 Untitled Letter to Mirati Therapeutics Inc.
FDA Law
FEBRUARY 29, 2024
If the confirmatory trial shows that the drug actually provides a clinical benefit, then the FDA grants traditional approval for the drug. If the confirmatory trial does not show that the drug provides clinical benefit, FDA has regulatory procedures in place that could lead to removing the drug from the market. FDA-2022-E-3124 ).
Expert insights. Personalized for you.
98 
Let's personalize your content